Ozempic Kidney Trial Sinks Dialysis Stocks The Wall Street Journal

The weight-loss revolution is shaking another industry. Kidney-dialysis stocks sank Wednesday after Novo Nordisk (NVO), (DK: NOVO.B) said a trial showed its blockbuster diabetes drug Ozempic could d… [+251 chars]Read More